Yüklüyor......

Selection of a Surrogate Agent (Vancomycin or Teicoplanin) for Initial Susceptibility Testing of Dalbavancin: Results from an International Antimicrobial Surveillance Program

The immediate lack of market-dominating commercial products (Vitek or MicroScan) for susceptibility testing of the new glycolipopeptide, dalbavancin, requires a surrogate marker agent to assist microbiologists in the correct categorization of potentially indicated species (staphylococci and streptoc...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Jones, Ronald N., Sader, Helio S., Fritsche, Thomas R., Hogan, Patricia A., Sheehan, Daniel J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2006
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1489506/
https://ncbi.nlm.nih.gov/pubmed/16825398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.00576-06
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!